Galecto, Inc.

Informe acción NasdaqCM:GLTO

Capitalización de mercado: US$7.3m

Galecto Dirección

Dirección controles de criterios 3/4

Galecto's CEO is Hans Schambye, appointed in Jan 2020, has a tenure of 4.83 years. total yearly compensation is $965.12K, comprised of 52.4% salary and 47.6% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth $14.16K. The average tenure of the management team and the board of directors is 3.5 years and 4.5 years respectively.

Información clave

Hans Schambye

Chief Executive Officer (CEO)

US$965.1k

Compensación total

Porcentaje del salario del CEO52.4%
Permanencia del CEO4.8yrs
Participación del CEO0.2%
Permanencia media de la dirección3.5yrs
Promedio de permanencia en la Junta Directiva4.5yrs

Actualizaciones recientes de la dirección

Recent updates

Is Galecto (NASDAQ:GLTO) In A Good Position To Invest In Growth?

Jan 10
Is Galecto (NASDAQ:GLTO) In A Good Position To Invest In Growth?

Here's Why Galecto (NASDAQ:GLTO) Must Use Its Cash Wisely

May 17
Here's Why Galecto (NASDAQ:GLTO) Must Use Its Cash Wisely

Will Galecto (NASDAQ:GLTO) Spend Its Cash Wisely?

Feb 01
Will Galecto (NASDAQ:GLTO) Spend Its Cash Wisely?

Galecto’s GB1211 to be studied for phase 2 trial in combination with pembrolizumab to treat cancer

Oct 19

Here's Why We're Watching Galecto's (NASDAQ:GLTO) Cash Burn Situation

Oct 19
Here's Why We're Watching Galecto's (NASDAQ:GLTO) Cash Burn Situation

Galecto GAAP EPS of -$0.67 beats by $0.02

Jul 29

We're Keeping An Eye On Galecto's (NASDAQ:GLTO) Cash Burn Rate

Jun 30
We're Keeping An Eye On Galecto's (NASDAQ:GLTO) Cash Burn Rate

Is Galecto (NASDAQ:GLTO) In A Good Position To Deliver On Growth Plans?

Mar 10
Is Galecto (NASDAQ:GLTO) In A Good Position To Deliver On Growth Plans?

Galecto: Selling At Cash Value

Dec 19

We're Keeping An Eye On Galecto's (NASDAQ:GLTO) Cash Burn Rate

Nov 18
We're Keeping An Eye On Galecto's (NASDAQ:GLTO) Cash Burn Rate

Here's Why We're Watching Galecto's (NASDAQ:GLTO) Cash Burn Situation

Jul 07
Here's Why We're Watching Galecto's (NASDAQ:GLTO) Cash Burn Situation

Galecto EPS misses by $0.07

May 04

We Think Galecto (NASDAQ:GLTO) Can Afford To Drive Business Growth

Mar 23
We Think Galecto (NASDAQ:GLTO) Can Afford To Drive Business Growth

Do Institutions Own Galecto, Inc. (NASDAQ:GLTO) Shares?

Jan 29
Do Institutions Own Galecto, Inc. (NASDAQ:GLTO) Shares?

Galecto EPS misses by $41.65

Dec 11

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Hans Schambye en comparación con los beneficios de Galecto?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

-US$21m

Jun 30 2024n/an/a

-US$25m

Mar 31 2024n/an/a

-US$31m

Dec 31 2023US$965kUS$506k

-US$38m

Sep 30 2023n/an/a

-US$46m

Jun 30 2023n/an/a

-US$52m

Mar 31 2023n/an/a

-US$58m

Dec 31 2022US$1mUS$473k

-US$62m

Sep 30 2022n/an/a

-US$61m

Jun 30 2022n/an/a

-US$60m

Mar 31 2022n/an/a

-US$55m

Dec 31 2021US$3mUS$512k

-US$52m

Sep 30 2021n/an/a

-US$42m

Jun 30 2021n/an/a

-US$44m

Mar 31 2021n/an/a

-US$43m

Dec 31 2020US$4mUS$387k

-US$35m

Sep 30 2020n/an/a

-US$57m

Jun 30 2020n/an/a

-US$48m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$479kUS$360k

-US$42m

Compensación vs. Mercado: Hans's total compensation ($USD965.12K) is above average for companies of similar size in the US market ($USD655.65K).

Compensación vs. Ingresos: Hans's compensation has been consistent with company performance over the past year.

CEO

Hans Schambye (58 yo)

4.8yrs

Permanencia

US$965,115

Compensación

Dr. Hans T. Schambye, MD, Ph D, serves as Member of Board of Directors at BioInnovation Institute. Dr. Schambye is Co-Founder and has been Chief Executive Officer and Director at Galecto, Inc. since 2020 a...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Hans Schambye
Co-Founder4.8yrsUS$965.12k0.19%
$ 14.2k
Garrett Winslow
Senior VP3.5yrsUS$554.39k0.015%
$ 1.1k
Ulf Nilsson
Co-Founderno datasin datossin datos
Hakon Leffler
Co-Founderno datasin datossin datos
Tariq Sethi
Co-Founderno datasin datossin datos
Lori Firmani
Interim Chief Financial Officerless than a yearsin datossin datos

3.5yrs

Permanencia media

51yo

Promedio de edad

Equipo directivo experimentado: GLTO's management team is considered experienced (3.5 years average tenure).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Hans Schambye
Co-Founder4.8yrsUS$965.12k0.19%
$ 14.2k
Carl Goldfischer
Independent Chairman of the Board4.8yrsUS$155.19k0.035%
$ 2.6k
David Shapiro
Independent Director4.5yrsUS$148.84k0%
$ 0
Amit Munshi
Independent Director4.5yrsUS$78.85k0.018%
$ 1.3k
Anne Prener
Independent Director3.8yrsUS$83.85k0%
$ 0
Jayson Donald Dallas
Independent Director4yrsUS$86.35k0%
$ 0
Jonathan Fallowfield
Member of Clinical Advisory Board – Liver cirrhosisno datasin datossin datos
Adam Mead
Member of the Clinical Advisory Board - Myelofibrosisno datasin datossin datos
Aaron Gerds
Member of the Clinical Advisory Board - Myelofibrosisno datasin datossin datos
Claire Harrison
Member of the Clinical Advisory Board - Myelofibrosisno datasin datossin datos
John Mascarenhas
Member of the Clinical Advisory Board - Myelofibrosisno datasin datossin datos
Raajit Rampal
Member of the Clinical Advisory Board - Myelofibrosisno datasin datossin datos

4.5yrs

Permanencia media

61.5yo

Promedio de edad

Junta con experiencia: GLTO's board of directors are considered experienced (4.5 years average tenure).